Journal Watch

Open

Advertisement

Journal Watch

1-20 of 2236 results
1 2 3 4 5 Next »

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: the AVATAR trial.

Mar 23, 2022 by
Michael Mahmoudi, MD - M Banovic, et al.; Circ 2022; 145:648-58

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: the AVATAR trial.

CT or invasive coronary angiography in stable chest pain

Mar 23, 2022 by
Michael Mahmoudi, MD - The DISCHARGE trial group.; NEJM 2022 Online

CT or invasive coronary angiography in stable chest pain

High-sensitivity troponin I after cardiac surgery and 30-day mortality

Mar 23, 2022 by
Michael Mahmoudi, MD - P Devereaux, et al.; NEJM 2022; 386:827-36

High-sensitivity troponin I after cardiac surgery and 30-day mortality

Amulet or Watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial

Mar 23, 2022 by
Michael Mahmoudi, MD - R Galea, et al.; Circ 2022; 145:724-38

Amulet or Watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial

A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.

Jan 31, 2022 by
Michael Mahmoudi, MD - R Mehran, et al.; Lancet 2021; 398:1974-81

A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.

Jan 31, 2022 by
Michael Mahmoudi, MD - M Nazarzadeh, et al.; Lancet 2021; 398:1974-83

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.

Outcome of participants with diabetes in the ISCHEMIA trial

Jan 31, 2022 by
Michael Mahmoudi, MD - J Newman, et al; Circ 2021; 144:1380-95

Outcome of participants with diabetes in the ISCHEMIA trial

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator initiated, open

Jan 31, 2022 by
Michael Mahmoudi, MD - C Kim, et al.; Lancet 2021; 389:1803-10

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator initiated, open-label, multicentre, non-inferiority, randomised trial.

Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR).

Dec 31, 2021 by
Michael Mahmoudi, MD - D Collison, et al.; EHJ 2021; 42:4656-68

Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR).

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

Dec 31, 2021 by
Michael Mahmoudi, MD - G Witberg, et al.; NEJM 2021; 385:2132-39

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair and Implications of Interventional Closure.

Dec 31, 2021 by
Michael Mahmoudi, MD - P Lurz, et al.; JACC Cardiovasc Interv 2021; 14:2685-94

Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair and Implications of Interventional Closure.

Subclinical leaflet thrombosis after transcatheter aortic valve replacement.

Dec 31, 2021 by
Michael Mahmoudi, MD - M Bogyi, et al.; A meta-analysis.

Subclinical leaflet thrombosis after transcatheter aortic valve replacement.

Trends in transcatheter and surgical aortic valve replacement among older adults in the United States.

Dec 08, 2021 by
Michael Mahmoudi, MD - M Mori, et al.; JACC 2021; 78:2161-72

Trends in transcatheter and surgical aortic valve replacement among older adults in the United States.

Fractional flow reserve-guided PCI as compared with coronary bypass surgery

Dec 08, 2021 by
Michael Mahmoudi, MD - W Fearon, et al.; NEJM 2021 Online

Fractional flow reserve-guided PCI as compared with coronary bypass surgery

Concomitant tricuspid repair in patients with degenerative mitral regurgitation

Dec 08, 2021 by
Michael Mahmoudi, MD - J Gammie, et al.; NEJM 2021 Online

Concomitant tricuspid repair in patients with degenerative mitral regurgitation

Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomized, sham-controlled trial.

Dec 08, 2021 by
Michael Mahmoudi, MD - B Xu, et al.; Lancet 2021 Online

Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomized, sham-controlled trial.

Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest. The CAPITAL CHILL Randomized Clinical Trial.

Oct 25, 2021 by
Michael Mahmoudi, MD - M Le May, et al.; JAMA 2021; 326:1494-1503

Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest. The CAPITAL CHILL Randomized Clinical Trial.

Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.

Oct 25, 2021 by
Michael Mahmoudi, MD - N Curzen, et al.; EHJ 2021; 42:3844-52

Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.

ACTIVATION (percutaneous coronary intervention prior to transcatheter aortic valve implantation). A randomized clinical trial.

Oct 25, 2021 by
Michael Mahmoudi, MD - T Patterson, et al.; JACC Cardiol Intv 2021; 14:1965-74

ACTIVATION (percutaneous coronary intervention prior to transcatheter aortic valve implantation). A randomized clinical trial.

Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.

Oct 25, 2021 by
Michael Mahmoudi, MD - F Bouisset, et al.; JACC 2021; 78:1291-1305

Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.

1-20 of 2236 results
1 2 3 4 5 Next »

CRTonline on Facebook

CRT Meeting

CRTonline on Twitter

Tweets by CRT_meeting

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Refine Your Results

Search

Track

Type

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: the AVATAR trial.

CT or invasive coronary angiography in stable chest pain

High-sensitivity troponin I after cardiac surgery and 30-day mortality

Amulet or Watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial

A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.

Outcome of participants with diabetes in the ISCHEMIA trial

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator initiated, open

Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR).

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair and Implications of Interventional Closure.

Subclinical leaflet thrombosis after transcatheter aortic valve replacement.

Trends in transcatheter and surgical aortic valve replacement among older adults in the United States.

Fractional flow reserve-guided PCI as compared with coronary bypass surgery

Concomitant tricuspid repair in patients with degenerative mitral regurgitation

Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomized, sham-controlled trial.

Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest. The CAPITAL CHILL Randomized Clinical Trial.

Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.

ACTIVATION (percutaneous coronary intervention prior to transcatheter aortic valve implantation). A randomized clinical trial.

Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.

Explore the Site

Stay Connected

Journal Watch

Refine Your Results

Search

Track

Type

CRTonline on Facebook

CRTonline on Twitter

Explore the Site

Stay Connected